A critical moment: Standardizing red blood cell antibody reporting to reduce hemolytic disease of the fetus and newborn risk

Documenti analoghi

• Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States
  di: Jeremy W. Jacobs, et al.
  Pubblicazione: (2024)
• Double trouble: A baby with concurrent hemolytic disease of the fetus and newborn and neonatal alloimmune thrombocytopenia
  di: Regina M. DelBaugh, et al.
  Pubblicazione: (2025)
• A prehospital protocol for transfusion of low‐titer O‐positive whole blood in patients with hemorrhagic shock in Los Angeles County: Modeling the risk of hemolytic disease of the fetus and newborn
  di: Kelsey Wilhelm, et al.
  Pubblicazione: (2025)
• Antenatal risk estimation for exchange transfusions in neonates with hemolytic disease of the fetus and newborn in a changing treatment landscape: A multicenter, retrospective cohort study
  di: Derek P. de Winter, et al.
  Pubblicazione: (2025)
• A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system
  di: Brett Wilson, et al.
  Pubblicazione: (2024)